The following are today's upgrades for Validea's Contrarian Investor model based on the published strategy of David Dreman. This contrarian strategy finds the most unpopular mid- and large-cap stocks in the market and looks for improving fundamentals.
The following are today's upgrades for Validea's Growth/Value Investor model based on the published strategy of James P. O'Shaughnessy. This two strategy approach offers a large-cap value model and a growth approach that looks for persistent earnings growth and strong relative
The following are today's upgrades for Validea's Earnings Yield Investor model based on the published strategy of Joel Greenblatt. This value model looks for companies with high return on capital and earnings yields.
The following are today's upgrades for Validea's Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth that trade at a discount relative to their earnings growth and dividend yield.
The following are today's upgrades for Validea's Book/Market Investor model based on the published strategy of Joseph Piotroski. This value-quant strategy screens for high book-to-market stocks, and then separates out financially sound firms by looking at a host of improving f
The following are today's upgrades for Validea's Price/Sales Investor model based on the published strategy of Kenneth Fisher. This value strategy rewards stocks with low P/S ratios, long-term profit growth, strong free cash flow and consistent profit margins.
The following are today's upgrades for Validea's Small-Cap Growth Investor model based on the published strategy of Motley Fool. This strategy looks for small cap growth stocks with solid fundamentals and strong price performance.
The following are today's upgrades for Validea's P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relative to earnings growth that also possess strong balance sheets.
The following are today's upgrades for Validea's Patient Investor model based on the published strategy of Warren Buffett. This strategy seeks out firms with long-term, predictable profitability and low debt that trade at reasonable valuations.
The warning by the US Center for Disease Control and Prevention that Americans should prepare for an outbreak of Covid-19 sent the S&P 500 tumbling to an 11-week low and the 10-year Treasury yield to a record low near 1.30%.
Stocks plunged another 3% on Tuesday as the market continues to worry about the coronavirus spreading outside of China… and possibly having a much bigger impact here in the U.S.
It may be hard to remember now, but the market actually attempted a partial comeback this mornin
Lowe's (NYSE: LOW) on Wednesday announced earnings results showed it is still trailing its major retailing rival Home Depot (NYSE: HD). Yet the home improvement giant had some good news to report on the profitability front.
You might think that skyrocketing sales would translate to tremendous share price appreciation. But that wasn't the case for GW Pharmaceuticals (NASDAQ: GWPH) in 2019. The stock finished the year up only 7% while the S&P 500 index soared close to 29%. However, GW has gotten
(RTTNews) - Canadian Imperial Bank of Commerce (CM.TO) will host a conference call at 8:00 AM ET on February 26, 2020, to discuss Q1 20 earnings results.
Turkey plans to push Syrian government forces away from its military observation posts in northwest Syria's Idlib region by end-February, President Tayyip Erdogan said on Wednesday, despite advances by the Russian-backed government forces.
(RTTNews) - French stocks fell sharply on Wednesday to extend losses from the previous session as investors fretted over the rapidly-spreading coronavirus, which has now spread to several countries in Europe and the Middle East.